|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Program of the 2nd International Workshop on Waldenström's macroglobulinemiaSeptember 26-30, 2002
|
||
| Friday, September 27, 2002 | Astir Palace | |
|
7:00 AM |
Breakfast |
|
| Session I: Genetic basis and pathogenesis of WM | ||
| Part I | Chair: Dr. Pilarski (Canada) | |
|
8:00 AM |
Dr. Pilarski (Canada)# |
|
|
8:15 AM |
Dr. Sahota (UK)# |
|
|
8:30 AM |
Dr. Fonseca (USA) |
|
|
8:45 AM |
Dr. McMaster (USA) |
|
|
9:00 AM |
Dr. Shaughnessy (USA) |
|
|
|
||
|
9:15-9:30 |
Dr. Pilarski (Canada) |
Panel Discussion |
|
|
||
| Session I: Genetic basis and pathogenesis of WM | ||
| Part II | Chair: Dr. Avet-Loiseau (France) | |
|
9:30 AM |
Dr. Avet-Loiseau (France) |
|
|
9:45 AM |
Dr. N. Mitsiades (USA) |
|
|
10:00 AM |
Dr. Leitch (UK)* |
|
|
10:15 AM |
Dr. Adamia (Canada)* |
Overexpression and novel splice variants of Hyaluronan synthases in WM |
|
|
||
|
10:30-10:45 |
Dr. Avet-Loiseau (France) |
Panel Discussion |
|
|
||
|
10:45-11:00 |
Session Break |
Refreshments |
|
|
||
| Session II IgM Monoclonal gammopathies | ||
| Chair: Dr. Kyle (USA) | ||
|
11:00 AM |
Dr. Kyle (USA) |
|
|
11:15 AM |
Dr. Morra (Italy) |
|
|
11:30 AM |
Dr. Montoto (Spain)* |
|
|
|
||
|
11:45-12:00 |
Dr. Kyle (USA) |
Panel Discussion |
|
|
||
|
12:00-1:15 |
Lunch |
|
|
|
||
| Session III Defining Waldenström's macroglobulinemia | ||
| Chair: Dr. Alexanian (USA) | ||
|
1:15 PM |
Dr. Remstein (USA) |
|
|
1:30 PM |
Dr. San Miguel (Spain) |
|
|
1:45 PM |
Dr. Roger Owen (UK) |
|
|
2:00 PM |
Dr. Pangalis (Greece) |
|
|
2:15 PM |
Dr. Alexanian (USA) |
|
|
|
||
|
2:30-2: 45 |
Dr. Alexanian (USA) |
Panel Discussion |
|
|
||
| Session IV Report of Consensus Panel One | ||
|
Co-Chairs: Dr. Dimopoulos (Greece) and Dr. Owen (UK) |
||
|
2:45-4:15 |
Dr. Owen (UK) |
Report of Consensus Panel One on the Clinicopathological definition of WM |
|
Dr. Dimopoulos (Greece) |
Discussion and Consensus Summary |
|
|
|
||
|
4:15-4:45 |
Session Break |
Refreshments |
|
|
||
| Session V Prognostic Markers in Waldenström's macroglobuilinemia | ||
| Chair: Dr. Barlogie (USA) | ||
|
4:45 PM |
Dr. Merlini (Italy) |
|
|
5:00 PM |
Dr. Morel (France) |
Prognostic Factors in WM: Description of complications during disease evolution |
|
5:15 PM |
Dr. Barlogie (USA) |
Prognostic factors and response to Fludarabine: Update from a U.S. Intergroup Trial |
|
5:30 PM |
Dr. Bjorkholm (Sweden) |
|
|
5:45 PM |
Dr. Cesana (Italy)* |
Smoldering WM: Factors predicting evolution to symptomatic disease |
|
|
||
|
6:00-6:30 |
Dr. Barlogie (USA) |
Panel Discussion |
|
|
||
|
7:30 PM |
Night Tour of Athens and Dinner Reception at Dionysos in Plaka |
|
|
|
||
|
*Young Investigator Fellowship Award Recipient |
||
|
# Smokler Research Grant recipient |
||
| << Thursday, September 26 | Saturday, September 28 >> | ||